Air Lease Corporation Announces Second Quarter 2017 Results
Aug 03, 2017 20:01 pm UTC| Business
LOS ANGELES, Aug. 03, 2017 -- Air Lease Corporation (ALC) (NYSE:AL) announces financial results for the three and six months ended June 30, 2017. • Revenues: $381 million for the three months ended June 30, 2017, an...
Aug 03, 2017 20:01 pm UTC| Business
2Q’17 financial results reflect the first 4 weeks of TYMLOS sales in the U.S. Managed care contracts in place for coverage of over 130 million lives for TYMLOS™ (68% of all Commercial and 28% of Medicare) point to strong...
New York Mortgage Trust Reports Second Quarter 2017 Results
Aug 03, 2017 20:01 pm UTC| Business
NEW YORK, Aug. 03, 2017 -- New York Mortgage Trust, Inc. (Nasdaq:NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today reported results for the three and six months ended June 30, 2017. Summary of Second Quarter...
Sportsman's Warehouse Holdings, Inc. Announces Second Quarter 2017 Earnings Conference Call
Aug 03, 2017 20:01 pm UTC| Business
MIDVALE, Utah, Aug. 03, 2017 -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's" or the "Company") (Nasdaq:SPWH) today announced that it will hold its quarterly conference call to discuss second quarter 2017...
Vital Therapies Announces Second Quarter 2017 Financial Results
Aug 03, 2017 20:01 pm UTC| Business
SAN DIEGO, Aug. 03, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the...
NV5 Announces Record Second Quarter and Year-to-Date 2017 Financial Results; Raises Guidance
Aug 03, 2017 20:01 pm UTC| Business
HOLLYWOOD, Fla., Aug. 03, 2017 -- NV5 Global, Inc. (Nasdaq:NVEE) (“NV5” or the “Company”), a provider of professional and technical engineering and consulting solutions, today reported financial results for the second...
Cara Therapeutics Reports Second Quarter 2017 Financial Results
Aug 03, 2017 20:01 pm UTC| Business
STAMFORD, Conn., Aug. 03, 2017 -- Cara Therapeutics, Inc. (NASDAQ:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...